Aurobindo Pharma’s US FDA woes deepen.
Unit II in Bhiwadi gets ‘Official Action Indicated’ classification after inspection, raising concerns over regulatory compliance.
Subscribe To Our Free Newsletter |
Aurobindo Pharma’s US FDA woes deepen.
Unit II in Bhiwadi gets ‘Official Action Indicated’ classification after inspection, raising concerns over regulatory compliance.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!